H K Müller-Hermelink

Quality Assurance in Immunohistochemistry: Results of an Interlaboratory Trial Involving 172 Pathologists

Thomas Rüdiger, H. Müller-Hermelink, H. Höfler, 2002, The American journal of surgical pathology.

14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.

M Sieber, A Engert, H. Eich, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).

R. Gascoyne, H. Müller-Hermelink, K. Maclennan, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.